Terms: = Colorectal cancer AND LPP, Q93052, 4026, ENSG00000145012 AND Treatment
2 results:
1. Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).
Schimanski CC; Kasper S; Hegewisch-Becker S; Schröder J; Overkamp F; Kullmann F; Bechstein WO; Vöhringer M; Öllinger R; Lordick F; Heinemann V; Geißler M; Schulz-Abelius A; Bernhard H; Schön MR; Greil R; Galle P; Lang H; Schmidtmann I; Moehler M
Oncoimmunology; 2020 Aug; 9(1):1806680. PubMed ID: 32923171
[TBL] [Abstract] [Full Text] [Related]
2. Autocrine BMP-4 Signaling Is a Therapeutic Target in colorectal cancer.
Yokoyama Y; Watanabe T; Tamura Y; Hashizume Y; Miyazono K; Ehata S
Cancer Res; 2017 Aug; 77(15):4026-4038. PubMed ID: 28611046
[TBL] [Abstract] [Full Text] [Related]
